![]() ![]() New: AB 149 - New requirements for controlled substances prescription forms New: Prescribing and Reporting Rules for Controlled Substances Effective January 1, 2021 New: Notice Regarding COVID-19 Vaccine Administration New: AB 2113 - Expedited Licensure for Refugee Status Outreach #Elicense dca ca gov ilicense ilicense for free#Additionally, CVS, Rite Aid and Walgreen pharmacies now offer limited appointments for free COVID-19 vaccinations in select areas. #Elicense dca ca gov ilicense ilicense how to#The state’s website has information on vaccination eligibility, how to sign up for an appointment via MyTurn.ca.gov, local health jurisdiction resources, and more. Learn more about how to get vaccinated by visiting the state’s COVID-19 website →. Read the CDPH provider bulletin for details: New: CURES Fee Increase Effective April 1, 2021ĬOVID19 Update: Beginning March 15, COVID-19 vaccine eligibility has expanded. SCAM ALERT: Fake Board Representative or DEA Agent Extortion Scam New: Health Care Workers and Vaccination Requirements New: Telehealth Information Pursuant to Executive Order N-16-21 Practitioners also can get answers to questions about complying with the law at Electronic Data Transmission Prescriptions (E-Prescriptions) – Frequently Asked Questions provided by the California State Board of Pharmacy. For more information on this law and its requirements, please see the AB 2789 bulletin. ![]() Beginning January 1, 2022, most prescriptions (including but not limited to prescriptions for controlled substances) issued by a licensed healthcare practitioner to a California pharmacy must be submitted electronically. Licensees of the Osteopathic Medical Board of California with prescribing authority are subject to the e-prescribing requirements established by Assembly Bill (AB) 2789 (Wood, 2018). New: New Prescribing Laws Take Effect January 1, 2022. New: CDPH: Direct Ordering of Monoclonal Antibodies New: CDPH: Monoclonal Antibody Treatment Information for Providers and Facilities New: Licensing Laws Take Effect January 1, 2022 For information on how licensees of DCA boards are impacted by this change, please see the New Data Collection Vendor For Cures document on the DOJ CURES webpage. The California Department of Justice (DOJ) recently awarded the contract for prescription data collection services for the Controlled Substance Utilization Review and Evaluation System (CURES) to a new vendor. New: CURES Data Collection Vendor Change – Action Required by February 23, 2022 ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |